OTC Markets OTCPK - Delayed Quote USD

Avacta Group Plc (AVCTF)

Compare
0.6524 -0.0466 (-6.67%)
As of November 6 at 10:07 AM EST. Market Open.
All All Favorites Text Statistics Technicals Fibonacci Markings Lines
Loading Chart for AVCTF

Recent News: AVCTF

View More
Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona

Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona
Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology

Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology
Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION? Platform

Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION? Platform
Avacta Group strengthens executive team with appointment of?Michelle Morrow, PhD?as Chief Scientific Officer

Avacta Group strengthens executive team with appointment of?Michelle Morrow, PhD?as Chief Scientific Officer
Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium

Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium
Avacta Group First Half 2024 Earnings: UK￡0.038 loss per share (vs UK￡0.043 loss in 1H 2023)

Avacta Group First Half 2024 Earnings: UK￡0.038 loss per share (vs UK￡0.043 loss in 1H 2023)
Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors

Avacta Reports Updated Phase 1 Clinical Data of AVA6000 at the European Society for Medical Oncology (ESMO) Congress Demonstrating Multiple Ongoing, Durable Responses in Solid Tumors
Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress

Avacta to present updated clinical data on AVA6000 at the European Society for Medical Oncology (ESMO) Congress
Avacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%

Avacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%
Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors

Avacta Announces the Appointment of Darlene Deptula-Hicks as Non-Executive Director of the Board of Directors
Avacta Group (LON:AVCT) investors are sitting on a loss of 82% if they invested three years ago

Avacta Group (LON:AVCT) investors are sitting on a loss of 82% if they invested three years ago
View More

Related Tickers